Pharma Journalist -

ACADIA Pharmaceuticals Inc. announced that Elena Ridloff, CFA, has been appointed to the newly created position of Senior Vice President, Investor Relations, leading investor and…
Read More...

Exelixis announced that it has entered into a collaboration with Invenra, Inc., the Madison, Wisconsin-based biotechnology firm focused on developing next-generation biologics, to…
Read More...

Bactevo Ltd. announced that it has entered into a drug discovery collaboration agreement with Boehringer Ingelheim to identify novel small molecule lead compounds. This collaboration…
Read More...

Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the launch of Doxazosin Tablets, USP, 1 mg, 2 mg, 4 mg and 8 mg. The product was approved by the U.S. Food and Drug…
Read More...

Bioniz Therapeutics announced top-line results from its multiple ascending dose Phase 1b clinical trial of BNZ-1, a novel multi-cytokine inhibitor targeting interleukin (IL)-2, IL-9,…
Read More...

THE FUTURE OF INJECTABLE DRUG DEVICES IS HERE! The highly anticipated 3-day conference will gather the growing injectable drugs community, filled with industry thought leaders and…
Read More...

Biogen and Neurimmune announced that Biogen has exercised its option to further reduce the previously negotiated royalty rates payable on potential future sales of aducanumab, Biogen’s…
Read More...

SMi Group reports: Pain Therapeutics conference is a one-stop shop to discover all of the cutting-edge news, updates and case-studies regarding developments in the field of analgesic…
Read More...

Novartis announced the launch of its FocalView app, an ophthalmic digital research platform created with ResearchKit. FocalView aims to allow researchers to track disease progression by…
Read More...

AbbVie announced that it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration for risankizumab, an investigational interleukin-23 (IL-23)…
Read More...